Reuters logo
BRIEF-Vistin Pharma: extended announcement on selling opioids and CMO business
July 13, 2017 / 5:37 AM / 4 months ago

BRIEF-Vistin Pharma: extended announcement on selling opioids and CMO business

July 13 (Reuters) - VISTIN PHARMA ASA

* REG-VISTIN PHARMA ASA : AGREEMENT TO SELL OPIOIDS AND CMO BUSINESS - EXTENDED ANNOUNCEMENT

* TRANSACTION WILL HAVE A POSITIVE NET CASH EFFECT OF NOK 140 - 150 MILLION, BEFORE ANY TRANSACTION COSTS

* ‍SAYS TPI WILL PAY A CASH CONSIDERATION OF NOK 100 MILLION, AS WELL AS VALUE OF INVENTORY TRANSFERRED AT DATE OF CLOSING.​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below